Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma.
Jank BJ, Schnoell J, Kladnik K, Sparr C, Haas M, Gurnhofer E, Lein AL, Brunner M, Kenner L, Kadletz-Wanke L, Heiduschka G. Jank BJ, et al. Among authors: lein al. Oral Dis. 2023 May 8. doi: 10.1111/odi.14594. Online ahead of print. Oral Dis. 2023. PMID: 37154295
Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab.
Haas M, Lein A, Fuereder T, Schnoell J, Brkic FF, Liu DT, Kadletz-Wanke L, Heiduschka G, Jank BJ. Haas M, et al. Among authors: lein a. Invest New Drugs. 2023 Oct;41(5):727-736. doi: 10.1007/s10637-023-01388-x. Epub 2023 Aug 21. Invest New Drugs. 2023. PMID: 37603206 Free PMC article.
Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumab.
Haas M, Lein A, Fuereder T, Schnoell J, Brkic FF, Campion NJ, Liu DT, Kadletz-Wanke L, Heiduschka G, Jank BJ. Haas M, et al. Among authors: lein a. Int Immunopharmacol. 2023 Oct;123:110799. doi: 10.1016/j.intimp.2023.110799. Epub 2023 Aug 21. Int Immunopharmacol. 2023. PMID: 37598631